Home Pregnancy Test Study on BioBank Samples

Pregnancy Related Clinical Trial

Official title:

Home Pregnancy Test Study Lay User Study on BioBank Samples

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04610632
• Other study ID #: PROTOCOL-1147
• Status: Completed
• Start date: November 9, 2020
• Est. completion date: November 11, 2020

Study information

• Verified date: November 2020
• Source: SPD Development Company Limited
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

This is a non-clinical lay user study using stored clinical samples from the SPD BioBank.

Volunteers recruited into the study and meeting the criteria will test a randomised pregnant or not pregnant urine sample sourced from SPD's biobank with a new home pregnancy test. Volunteers will be required to follow the product instructions for use (IFU).

The order of testing will be randomised prior to execution of the protocol, and each urine sample will only be identifiable by a unique reference number. An independent study technician not involved in study conduct will be responsible for blinding the samples.

Description:

Women will be informed of the opportunity to participate in a study in which they will be required to use a home pregnancy test to test a urine sample provided to them. Interested applicants will be invited to join the study.

Volunteers will be advised that the product they will be testing is under investigation and that the volunteer will not be testing their own urine and therefore volunteers will not learn their own pregnancy status.

Volunteers will be required to consent to the study prior to participation. Each volunteer will test only one device, they will be provided with one investigational device and one urine sample. The order of testing will be randomised prior to execution of the protocol, and each urine sample will only be identifiable by a unique reference number.

When ready the volunteer will be required to read the IFU prior to testing the urine sample provided with the investigational device according to the instructions. The volunteer will advise the study technician of the result, who will record this on the result sheet.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 81
• Est. completion date: November 11, 2020
• Est. primary completion date: November 11, 2020
• Gender: Female
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Female

• Aged =18 years

• Willing to give informed consent

Exclusion Criteria:

• Currently or previously employed by SPD, Abbott, Alere, Unipath, P&G or affiliates

• Has an immediate relative currently or previously (within last 5 years) employed by SPD, Abbott, Alere, Unipath or P&G or affiliates

• Is a qualified or trainee Healthcare Professional (HCP)

• Has professional experience of using dipstick type tests or lateral flow devices

• Has previously taken part in this study

• Seen the product within the past 6 months

Related Conditions & MeSH terms

• Pregnancy Related

Intervention

Diagnostic Test:
• home pregnancy test
use of home pregnancy test

Locations

Country	Name	City	State
United Kingdom	SPD Development Company Ltd.	Bedford	Bedfordshire

Sponsors (1)

Lead Sponsor	Collaborator
SPD Development Company Limited

Country where clinical trial is conducted

United Kingdom, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Agreement with confirmed pregnancy result	The percentage agreement between the result obtained when a lay user test a urine sample, and the confirmed pregnancy status of the volunteer providing the sample. Both confirmed positive (pregnant) and negative (not pregnant) samples will be included in the study.	1 week